2 More Blood-Pressure Meds Recalled Over Cancer Risk

Teva Pharmaceuticals pulls them off the market
By Neal Colgrass,  Newser Staff
Posted Dec 1, 2018 5:35 PM CST
2 More Blood-Pressure Meds Recalled Over Cancer Risk
Stock photo.   (Getty Images)

Taking blood-pressure medication? Teva Pharmaceuticals is voluntarily recalling two drugs as part of an ongoing effort to take medications off the market that might cause cancer, USA Today reports. In an FDA-released statement, Teva says it's recalling all combination tablets using valsartan and amlodipine as well as a drug combining hydrochlorothiazide, valsartan, and amlodipine. Patients using them are advised to seek medical assistance in transferring to another drug. The move follows earlier recalls this year for other valsartan products and blood-pressure drugs made with irbesartan and losartan, per WebMD. (The FDA has also recalled Kratom.)

We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.
Get the news faster.
Tap to install our app.
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.